William Mitchell, MD
Sports Medicine · Wilson, NCNPI 1376836254
Payments from drug & device makers
Across 20 payments — averaging $28.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$151
- Stryker$81
- Smith+Nephew$71
- Bioventus LLC$66
- Vertex$45
- Fidia Pharma USA Inc.$25
- plus $134 from 8 others
Across 1 payment — averaging $565.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Deroyal Industries, Inc.$565
What the payments were for
- Food & beverage$571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $151 |
| Stryker | 1 | $81 |
| Smith+Nephew | 1 | $71 |
| Bioventus LLC | 3 | $66 |
| Vertex | 2 | $45 |
| Fidia Pharma USA Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Si-bone, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Molnlycke Health Care US, LLC | 1 | $16 |
| Coherus Oncology, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TFN ADVANCED$100
How this compares
$571 in reported general payments places this provider in the 35th percentile of 158 sports medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 186 | $1,238 |
| Celecoxib | 57 | $965 |
| Cyclobenzaprine Hcl | 139 | $857 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 86 | $799 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 86 | $783 |
| Tramadol Hcl | 158 | $535 |
| Indomethacin | 17 | $245 |
| Meloxicam | 78 | $181 |
| Ondansetron OdtOndansetron | 38 | $171 |
| Tamsulosin Hcl | 12 | $96 |
| Prednisone | 23 | $42 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Wilson
- Brian WatermanWinston Salem$466K
- Allston StubbsWinston Salem$184K
- Robert BoykinAsheville$143K
- Tally EddingsAsheville$109K
- William SilverDurham$82K
- Rebecca BassettGreensboro$69K
- Wallace HarrisAsheville$58K
- Alan ReynoldsGreensboro$54K
- Fletcher PreussCharlotte$53K
- Anthony MaroisSherrills Ford$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.